Egypt's GASC receives offer in local vegoils tender - trade
Egypt's state grains buyer, the General Authority for Supply Commodities (GASC,) is seeking an unspecified quantity of vegetable oils
Reuters News - 11 Apr 2021
Alexandria Co for Pharmaceuticals & Chemical Industries (AXPH.CA)
Also known as: Alex Co. Pharma, Alexandria Pharmaceuticals
138.89 EGP 2.701.983%
Alex Co. Pharma Stock Price & Performance
Recommendation
-
Div Yield
10.812%
P/E (Last 12 Month)
3.287
Upside
-
Target Price (Mean)
-
Open
138.47 EGP
Previous Close
136.19 EGP
Turnover
30.00K EGP
EPS
41.434 EGP
Volume
216
Transactions
8
Market Cap
680.95M EGP
IPO Date
27-Feb-1995
Analyst Estimates
| EPS | Revenue | |
|---|---|---|
| Mean Estimate |  | |
| Smart Estimate | | |
| Predicted Surprise | | |
| Mean Chg % | | |
Starmine Models
StarMine provides a suite of proprietary alpha-generating analytics and models spanning sectors, regions, and markets.
| Bullish | |
|---|---|
| Value Momentum | |
| Intrinsic Valuation | |
| Relative Valuation | |
| Credit Risk - Smart Ratios | |
| Credit Risk- Text Mining | |
| Bearish | |
|---|---|
| Price Momentum | |
About Alexandria Co for Pharmaceuticals & Chemical Industries
Business Summary
Manufacture of generic drugs, dental cartridges, medicated adhesive tapes, plasters, surgical gloves and sterile gauze dressing,eye drops, vitamins and veterinary products.
Country of Incorporation
Ownership Type
Established In
1962
Primary Sector
Stock Listing
| ID | Stock Type | Currency | Exchange | Symbol |
|---|---|---|---|---|
| AXPH.CASE | Ordinary | EGP | Egypt SE | AXPH |
Contact details
Primary address
Building: Alexandria Co for Pharmaceuticals & Chemical Industries BuildingStreet: Gamila Abou Herid Road
Area: Al Awayed Area
P.O. Box: 21511
Country: Egypt
City: Alexandria
CONTACT
- Tel: +20 3-331-0224
- Tel: +20 3-331-2226
- Fax: +20 3-330-2221
- www.alexcopharma.net
Region
AlexandriaOwnership
Ownership
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Holding Concentrations
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Financials
Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing
Executives
Dr Abla Youssef Abdullah
Managing Director
Mr Mohammed Khalifa
Information Technology Director
Dr Mohammed Ashraf
Head of Marketing
Board Members
Dr Abla Youssef Abdullah
Chairperson and director representing Drug Holding Company
Dr Mohammed Hasan Suleiman Rabih
Director
Mr Saifuddine Ahmad Abdulmoati
Director
Company information provided by Refinitiv
Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
Zawya Coverage
UAE: Flight ban from India, Pakistan could be extended beyond August 7
Energy transition: UAE's Mubadala Petroleum to increase natural gas production
ADIB sees rise in "digitally active" customers by 30% in six months
Saudi Al Rajhi Bank and Riyad Bank see jump in Q2 net profit
Saudi central bank's net foreign assets rose by $9bln in June 2021
Sunday Outlook: U.S. stocks slip on Amazon disappointment, dollar bounces
Oil climbs, notches fourth monthly gain on growing demand
Stock Market Data
Powered By Knowledge Direct